Acceptance and Adverse Effects of H1N1 Vaccinations among a Cohort of National Guard Health Care Workers during the 2009 Hajj Season

被引:12
作者
Ahmed G.Y. [1 ]
Balkhy H.H. [1 ,2 ,3 ,4 ]
Bafaqeer S. [5 ]
Al-Jasir B. [6 ]
Althaqafi A. [4 ,7 ]
机构
[1] King Abdullah International Medical Research Center, Riyadh
[2] Department of Pediatrics, King Saud Bin Abdulaziz University for Health Sciences, Riyadh
[3] Infection Prevention and Control, King Abdulaziz Medical City, Riyadh
[4] Gulf Cooperation Council (GCC) States, WHO Collaborating Center for Infection Prevention and Control, Riyadh
[5] Department of Pediatrics, King Abdulaziz Medical City, Jeddah
[6] Department of Family Medicine, King Abdulaziz Medical City, Jeddah
[7] Infection Prevention and Control, King Abdulaziz Medical City, Jeddah
关键词
Influenza; National Guard; H1N1 Vaccine; Vaccine Acceptance; H1N1 Vaccination;
D O I
10.1186/1756-0500-4-61
中图分类号
学科分类号
摘要
Background: The H1N1 influenza pandemic had garnered a large amount of attention. Currently, the most effective preventive measure available is the H1N1 vaccine. We aimed to assess the willingness of our study participants to receive the H1N1 vaccination prior to the annual Hajj season. If any participant declined, we investigated the reasons for vaccine rejection. Findings. We conducted a prospective cohort study of National Guard employees during the 1430 (2009) Hajj season. A survey was used as the primary method for data collection. Participants were vaccinated one to two weeks prior to their trip to Mona, and any side effects reported at the time of injection and three weeks post vaccination were recorded. There were 100 male and 26 female participants in the study. In total, 66.7% (n = 84) of the participants were health care workers (HCWs) and 33.3% (n = 42) were non-health care workers (non-HCWs). Less than half of the respondents (46.8%, n = 59) accepted the vaccination. The vaccination acceptance rate was higher among non-HCWs, at a rate of 71.4% (n = 30); HCWs only accepted at a rate of 34.5% (n = 29) (OR 1.103, 95% CI [0.488-2.496]). The most common reason for vaccine refusal was the impression that the disease was not fatal (25.4%, n = 32). Finally, all participants reported pain at the injection site and 18.3% (n = 11) reported swelling. All other side effects were reported in less than 15% of the participants. Conclusions: Despite fears of the new H1N1 vaccine, there was a reasonable rate of vaccine acceptance among our study participants. Early health education may increase the rate of acceptance of the H1N1 vaccine. Furthermore, additional research is needed on long-term adverse effects of the H1N1 vaccine. © 2011 Balkhy et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 20 条
  • [1] Balkhy H.H., Memish Z.A., Bafaqeer S., Almuneef M.A., Influenza a Common Viral Infection among Hajj Pilgrims: Time for Routine Surveillance and Vaccination, Journal of Travel Medicine, 11, 2, pp. 82-86, (2004)
  • [2] Memish Z.A., Ahmed Q.A., Mecca bound: The challenges ahead, J Travel Med, 9, 4, pp. 202-210, (2002)
  • [3] Qureshi H., Gessner B.D., Leboulleux D., Hasan H., Alam S.E., Moulton L.H., The incidence of vaccine preventable influenza-like illness and medication use among Pakistani pilgrims to the Haj in Saudi Arabia, Vaccine, 18, 26, pp. 2956-2962, (2000)
  • [4] El-Sheikh S.M., El-Assouli S.M., Mohammed K.A., Albar M., Bacteria and viruses that cause respiratory tract infections during the pilgrimage (Haj) season in Makkah, Saudi Arabia, Tropical Medicine and International Health, 3, 3, pp. 205-209, (1998)
  • [5] Potter C.W., A history of influenza, Journal of Applied Microbiology, 91, 4, pp. 572-579, (2001)
  • [6] Beigi R.H., Switzer G.E., Meyn L.A., Acceptance of a pandemic avian influenza vaccine in pregnancy, J Reprod Med, 54, 6, pp. 341-346, (2009)
  • [7] World Health Organization. Global Alert and Response. Pandemic H1N1 (2009) Update- 67
  • [8] Lau J.T., Yeung N.C., Choi K.C., Cheng M.Y., Tsui H.Y., Griffiths S., Acceptability of A/H1N1 vaccination during pandemic phase of influenza A/H1N1 in Hong Kong: Population based cross sectional survey, BMJ, 339, (2009)
  • [9] European Medicine Agency, EMEA
  • [10] Riddiough M.A., Willems J.S., Sanders C.R., Kemp K., Factors affecting the use of vaccines: Considerations for immunization program planners, Public Health Reports, 96, 6, pp. 528-535, (1981)